Chapter title |
The Psychosocial Impact of Atopic Dermatitis
|
---|---|
Chapter number | 6 |
Book title |
Management of Atopic Dermatitis
|
Published in |
Advances in experimental medicine and biology, January 2017
|
DOI | 10.1007/978-3-319-64804-0_6 |
Pubmed ID | |
Book ISBNs |
978-3-31-964803-3, 978-3-31-964804-0
|
Authors |
Heather Gochnauer, Rodrigo Valdes-Rodriguez, Leah Cardwell, Rachel B. Anolik |
Abstract |
Atopic dermatitis is a chronic skin condition which has significant psychosocial and quality of life impact. The condition causes physical discomfort, emotional distress, embarrassment, social stigma and daily activity limitation. In an effort to assess these aspects of disease burden, quality of life measurement tools were developed. Through use of these tools, we have expanded our knowledge of the psychosocial and quality of life burden of this condition. A variety of quality of life assessment tools exist, yet there is no consensus on which tool is best suited to assess the quality of life impact of atopic dermatitis. Research studies assessing quality of life in atopic dermatitis patients utilize a variety of quality of life measurement tools; this complicates comparisons across research studies. Though comparison across studies is difficult, the data echoes tremendous overall burden of disease, especially pertaining to psychosocial status and life quality. |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 36 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Master | 6 | 17% |
Student > Bachelor | 4 | 11% |
Lecturer | 3 | 8% |
Student > Ph. D. Student | 3 | 8% |
Student > Postgraduate | 2 | 6% |
Other | 4 | 11% |
Unknown | 14 | 39% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 8 | 22% |
Pharmacology, Toxicology and Pharmaceutical Science | 2 | 6% |
Engineering | 2 | 6% |
Biochemistry, Genetics and Molecular Biology | 2 | 6% |
Psychology | 2 | 6% |
Other | 6 | 17% |
Unknown | 14 | 39% |